PRESS RELEASE published on 02/06/2024 at 16:00, 2 years 3 months ago Cantabio Pharmaceuticals Awarded Major Grant from The Michael J. Fox Foundation for the Development of a novel DJ-1 Protein Replacement Therapy for the Treatment of Parkinson’s Disease Cantabio Pharmaceuticals, Inc. receives major grant from MJFF for the development of DJ-1 replacement therapy aimed at treating Parkinson's disease by increasing DJ-1 levels in patients and preventing disease progression Precision Medicine Cantabio Pharmaceuticals MJFF Grant DJ-1 Replacement Therapy Parkinson's Disease
Published on 05/21/2026 at 23:00, 3 hours 22 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 3 hours 22 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 3 hours 22 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 4 hours 7 minutes ago Linear Announces Acquisition, Share Consolidation and Private Placement
Published on 05/21/2026 at 21:45, 4 hours 36 minutes ago Rendeavour becomes the African Continental Free Trade Area's inaugural implementation partner for African industrialisation and trade infrastructure
Published on 05/21/2026 at 20:10, 6 hours 11 minutes ago Ernst Russ AG Divests MV 'EF Emira' and Raises Full-Year 2026 Guidance
Published on 05/21/2026 at 20:05, 6 hours 16 minutes ago EQS-Adhoc: Ernst Russ AG: Upward revision of the guidance for the financial year 2026
Published on 05/21/2026 at 20:00, 6 hours 21 minutes ago VINFAST INTRODUCES THE NEW-GENERATION VF 8, FEATURING COMPREHENSIVE ENHANCEMENTS
Published on 05/21/2026 at 18:26, 7 hours 55 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/21/2026 at 17:45, 8 hours 37 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 07:30, 18 hours 52 minutes ago Biophytis participates in the first Longevity Summit
Published on 05/20/2026 at 17:45, 1 day 8 hours ago Report on share repurchases from 13 to 19 May 2026